Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| palladium 103 prostate |
|
Prostate Cancer - First cases reported that used TheraSeed NewsRx is the leading source of news and information on Prostate Cancer. First cases reported that used TheraSeed Palladium-103 seeds in the isosleeve Chicago Prostate Cancer Center | Discharge Instructions - Palladium Palladium103 seeds emit only low energy x-rays. Very little radiation penetrates outside of the prostate gland. General radiation safety precautions are not Urology : Long-Term Prostate Cancer Control Using Palladium-103 14 M.J. Dattoli, K.E. Wallner and R. Sorace et al., Planned extracapsular seed placement using palladium-103 for prostate brachytherapy, J Brachyther Int 16 IngentaConnect Palladium-103 brachytherapy for prostate carcinoma Palladium-103 brachytherapy for prostate carcinoma. Authors: Blasko J.C.1; Grimm P.D.; Sylvester J.E.; Badiozamani K.R.; Hoak D.; Cavanagh W. IngentaConnect The effects of edema on urethral dose following The effects of edema on urethral dose after interstitial prostate brachytherapy with palladium-103 (103Pd) were studied. Fifty patients underwent a 90-Gy Brachytherapy (low dose rate)/Iodine -125/Palladium- 103 Palladium- 103. Localised Prostate Cancer. Early Prostate Cancer Table of Contents. The Problem Submitted For ARIF To Advise Upon. Reviews Identified Welcome to IEEE Xplore 2.0: Comparison of palladium-103 prostate Comparison of palladium-103 prostate implant dose distributionsusing a novel prostate phantom and commercial treatment planningsoftware incorporating TG-43 Long-Term Prostate Cancer Control Using Palladium-103 UroToday.com- Brachytherapy is recommended for low risk prostate cancer (CaP). For intermediate and high risk patients, some have advocated combining Prostate Cancer - Brachytherapy with Palladium-103 Better Than or Twelve-Year Research Proves Superior Efficacy of Seed Therapy for High- and Intermediate-Risk Prostate Cancer Patients - A new peer-reviewed study Comparison of palladium-103 prostate implant dose distributions Palladium-103 Prostate Implant Dose. Distributions Using. A. Novel Prostate Phantom and Commercial. Treatment Planning Software Incorporating TG-43 Palladium-103 in Prostate Cancer Brachytherapy palladium seeds are used for prostate cancer brachytherapy. |
| palladium 103 prostate |
|
inflammed prostate hormone refractory metastatic prostate cancer pain in prostate plastic prostate model |